This website is part of the ECDC (European Centre for Disease Prevention and Control) network
On the occasion of the 4th European Antibiotic Awareness Day, ECDC releases new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). According to the new data, resistance to last-line antibiotics is increasing in Europe. Several Member states report increasing percentage of Klebsiella pneumoniae, resistant to carbapenems - the major last-line class of antibiotics to treat infections with multidrug-resistant bacteria. The data also show that antibiotic resistance in general is increasing across Europe and represents a growing threat to the effectiveness of antibiotics.
ECDC has recently released two risk assessments on this subject. The risk assessment on the spread of New Delhi metallo-β-lactamase (NDM) published today stresses that NDM and other highly antibiotic resistant bacteria represent a risk for Europe as EU Member States lack the necessary surveillance systems and policies. Another recently issued ECDC Risk Assessment evaluated the risk to the citizens of Europe of carbapenemase-producing Enterobacteriaceae (CPE) spread through patient mobility.
This year, a new video produced by ECDC and Euronews features real life examples of the experiences of patients affected by resistant bacteria.